1.19BMarket Cap
LossP/E TTM
WAVE Life Sciences Ltd's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of WAVE Life Sciences Ltd is 7.13, ranking 260 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.85, which is -70.16% below the recent high of -1.74 and -459.59% above the recent low of -32.71.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.